Cargando…

Prevalence of Human Papillomavirus in Self-Taken Samples from Screening Nonattenders

The Copenhagen Self-Sampling Initiative (CSi) has shown how human papillomavirus (HPV)-based self-sampling can be used to increase screening participation among 23,632 nonattenders in the Capital Region of Denmark. In this study, we describe HPV prevalence and genotype frequency in 4,824 self-sample...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lam, J. U. H., Rebolj, M., Ejegod, D. M., Pedersen, H., Rygaard, C., Lynge, E., Harder, E., Thomsen, L. T., Kjaer, S. K., Bonde, J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2017
Materias:	Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5625377/ https://www.ncbi.nlm.nih.gov/pubmed/28724554 http://dx.doi.org/10.1128/JCM.00550-17

Ejemplares similares

Human papillomavirus self‐sampling for screening nonattenders: Opt‐in pilot implementation with electronic communication platforms
por: Lam, Janni Uyen Hoa, et al.
Publicado: (2017)

High-grade cervical intraepithelial neoplasia in human papillomavirus self-sampling of screening non-attenders
por: Lam, J U H, et al.
Publicado: (2018)

Differential Detection of Human Papillomavirus Genotypes and Cervical Intraepithelial Neoplasia by Four Commercial Assays
por: Rebolj, Matejka, et al.
Publicado: (2016)

Cross-reactivity profiles of hybrid capture II, cobas, and APTIMA human papillomavirus assays: split-sample study
por: Preisler, Sarah, et al.
Publicado: (2016)

Human Papillomavirus Assays and Cytology in Primary Cervical Screening of Women Aged 30 Years and Above
por: Rebolj, Matejka, et al.
Publicado: (2016)

HPV prevalence and genotype distribution in a population-based split-sample study of well-screened women using CLART HPV2 Human Papillomavirus genotype microarray system
por: Bonde, Jesper, et al.
Publicado: (2014)

Disagreement between Human Papillomavirus Assays: An Unexpected Challenge for the Choice of an Assay in Primary Cervical Screening
por: Rebolj, Matejka, et al.
Publicado: (2014)

Prevalence of Human Papillomavirus in 5,072 Consecutive Cervical SurePath Samples Evaluated with the Roche Cobas HPV Real-Time PCR Assay
por: Preisler, Sarah, et al.
Publicado: (2013)

Clinical and Analytical Performance of the BD Onclarity HPV Assay with SurePath Screening Samples from the Danish Cervical Screening Program Using the VALGENT Framework
por: Bonde, Jesper Hansen, et al.
Publicado: (2020)

Comparison of analytical and clinical performance of CLART HPV2 genotyping assay to Linear Array and Hybrid Capture 2: a split-sample study
por: Ejegod, Ditte Møller, et al.
Publicado: (2015)

Human papillomavirus testing in primary cervical screening and the cut-off level for hybrid capture 2 tests: systematic review
por: Rebolj, Matejka, et al.
Publicado: (2011)

The BD Onclarity HPV Assay on Samples Collected in SurePath Medium Meets the International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening
por: Ejegod, Ditte, et al.
Publicado: (2016)

Cervical histology after routine ThinPrep or SurePath liquid-based cytology and computer-assisted reading in Denmark
por: Rebolj, Matejka, et al.
Publicado: (2015)

Identifying Reasons for Nonattendance and Noncompletion of Cardiac Rehabilitation: INSIGHTS FROM GERMANY AND THE NETHERLANDS
por: Vonk, Thijs, et al.
Publicado: (2021)

Time and temperature dependent analytical stability of dry-collected Evalyn HPV self-sampling brush for cervical cancer screening
por: Ejegod, Ditte Møller, et al.
Publicado: (2018)

Complexities in the estimation of overdiagnosis in breast cancer screening
por: Duffy, S W, et al.
Publicado: (2008)

Nonattendance in pediatric pulmonary clinics: an ambulatory survey
por: Goldbart, Aviv D, et al.
Publicado: (2009)

Breast density and outcome of mammography screening: a cohort study
por: Olsen, A H, et al.
Publicado: (2009)

Incomplete follow-up of positive HPV tests: overview of randomised controlled trials on primary cervical screening
por: Rebolj, M, et al.
Publicado: (2010)

Breast cancer incidence after the start of mammography screening in Denmark
por: Olsen, A H, et al.
Publicado: (2003)

Cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in Norway
por: Burger, E A, et al.
Publicado: (2012)

Reasons for Nonattendance across the Hepatitis C Disease Course
por: Butt, Gail, et al.
Publicado: (2013)

Comparison of human papillomavirus‐based cervical cancer screening strategies in Tanzania among women with and without HIV
por: Kahesa, Crispin, et al.
Publicado: (2022)

Incidence of cervical precancerous lesions and cervical cancer in Denmark from 2000 to 2019: Population impact of multi‐cohort vaccination against human papillomavirus infection
por: Ring, Linea Landgrebe, et al.
Publicado: (2022)

Parity as a cofactor for high-grade cervical disease among women with persistent human papillomavirus infection: a 13-year follow-up
por: Jensen, K E, et al.
Publicado: (2013)

Papillomavirus infection in rural women in southern India
por: Franceschi, S, et al.
Publicado: (2005)

Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screening
por: Ejegod, Ditte Møller, et al.
Publicado: (2020)

Human papillomavirus DNA detected in fingertip, oral and bathroom samples from unvaccinated adolescent girls in Tanzania
por: Houlihan, Catherine F, et al.
Publicado: (2019)

Cost-effectiveness of cervical cancer screening: cytology versus human papillomavirus DNA testing
por: van Rosmalen, J, et al.
Publicado: (2012)

Prevalence and determinants of human papillomavirus infection and cervical lesions in HIV-positive women in Kenya
por: De Vuyst, H, et al.
Publicado: (2012)

Epidermodysplasia verruciformis human papillomavirus types and carcinoma of the conjunctiva: a pilot study
por: Ateenyi-Agaba, C, et al.
Publicado: (2004)

Human papillomavirus prevalence in women attending routine cervical screening in South Wales, UK: a cross-sectional study
por: Hibbitts, S, et al.
Publicado: (2008)

Human papillomavirus infection and use of oral contraceptives
por: Green, J, et al.
Publicado: (2003)

Long-term protective effect of high-risk human papillomavirus testing in population-based cervical screening
por: Bulkmans, N W J, et al.
Publicado: (2005)

Type- and age-specific distribution of human papillomavirus in women attending cervical cancer screening in Finland
por: Leinonen, M K, et al.
Publicado: (2013)

Prevalence and determinants of human papillomavirus genital infection in men
por: Franceschi, S, et al.
Publicado: (2002)

Stated Choice design comparison in a developing country: recall and attribute nonattendance
por: Iles, Richard A, et al.
Publicado: (2014)

Clinic Nonattendance Is a Risk Factor for Poor Kidney Transplant Outcomes
por: Richardson, Cathy, et al.
Publicado: (2018)

Evaluating the reasons for nonattendance to outpatient consultations: is waiting time an important factor?
por: Zykienė, Bernadeta, et al.
Publicado: (2022)

Risk Factors for Nonattendance in Delusional Infestation: A Multicenter Observational Study
por: Kemperman, Patrick, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ufjeg3um611tr6dt2039k4mpfv